marbofloxacin has been researched along with Actinobacillus Infections in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dorey, L; Lees, P | 1 |
| El Garch, F; Fraile, L; Giboin, H; Schneider, M; Vilalta, C | 1 |
| Dorey, L; Hobson, S; Lees, P | 1 |
3 other study(ies) available for marbofloxacin and Actinobacillus Infections
| Article | Year |
|---|---|
Impact of growth matrix on pharmacodynamics of antimicrobial drugs for pig pneumonia pathogens.
Topics: Actinobacillus Infections; Actinobacillus pleuropneumoniae; Animals; Anti-Bacterial Agents; Fluoroquinolones; Microbial Sensitivity Tests; Oxytetracycline; Pasteurella Infections; Pasteurella multocida; Pneumonia, Bacterial; Swine; Swine Diseases; Thiamphenicol | 2017 |
Pharmacokinetic/pharmacodynamic evaluation of marbofloxacin in the treatment of Haemophilus parasuis and Actinobacillus pleuropneumoniae infections in nursery and fattener pigs using Monte Carlo simulations.
Topics: Actinobacillus Infections; Actinobacillus pleuropneumoniae; Age Factors; Animals; Animals, Newborn; Anti-Bacterial Agents; Biological Availability; Drug Resistance, Bacterial; Fluoroquinolones; Haemophilus Infections; Haemophilus parasuis; Microbial Sensitivity Tests; Monte Carlo Method; Swine; Swine Diseases; Treatment Outcome | 2014 |
Factors influencing the potency of marbofloxacin for pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida.
Topics: Actinobacillus Infections; Actinobacillus pleuropneumoniae; Animals; Anti-Bacterial Agents; Fluoroquinolones; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Pasteurella Infections; Pasteurella multocida; Pneumonia; Swine; Swine Diseases | 2017 |